Accel Research Sites now enrolling healthy volunteers, 60 to 80 years old, for phase 1 trial
Nov.07, 2021 in
News
Investigational therapeutic could potentially treat IPF and lung conditions such as Long COVID.
Comments Off on Accel Research Sites now enrolling healthy volunteers, 60 to 80 years old, for phase 1 trial